FDA first amendment review
This article was originally published in The Rose Sheet
Executive Summary
Deadline for submitting comments regarding FDA's regulation of commercial speech will be extended 45 days to Sept. 13, agency announces July 3. Public also will have additional 45 days to respond to comments of others with a deadline set for Oct. 28. Extension will be published in upcoming Federal Register notice, FDA says. Agency requested public comment on the constitutionality of its regulation of marketing and advertising of cosmetics, drugs and other products May 16 (1"The Rose Sheet" May 20, 2002, p. 7)...
You may also be interested in...
FDA Commercial Speech Regs Constitutionality Debate Opened By Agency
FDA invites public comments on the constitutionality of its approach to regulating advertising and marketing practices for cosmetics, drugs and other products in a notice appearing in the May 16 Federal Register
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.